ADRA2C anticorps (C-Term, Cytosolic)
Aperçu rapide pour ADRA2C anticorps (C-Term, Cytosolic) (ABIN2199675)
Antigène
Voir toutes ADRA2C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term, Cytosolic
-
Séquence
- QDFRRSFKHI LFRRRRRGFR Q
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- Alpha-2C Adrenergic Receptor (Alpha-2 adrenergic receptor subtype C4, Alpha-2C adrenoreceptor, Alpha-2CAR, ADRA2C, ADRA2L2 and ADRARL2)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Synthetic peptide amino acids 442- 462 (QDFRRSFKHILFRRRRRGFRQ, cytoplasmic C-terminus) of human Alpha-2C adrenergic receptor, Accession# P18825
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS pH 7.4, 50 % glycerol.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ADRA2C (Adrenergic, alpha-2C-, Receptor (ADRA2C))
-
Autre désignation
- alpha-2C Adrenergic Receptor
-
NCBI Accession
- NP_000674
-
UniProt
- P18825
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Antigène
-